Lupin Moves Into Russia With Biocom Buy
This article was originally published in PharmAsia News
Executive Summary
Lupin has snapped up the Russian generic firm, ZAO Biocom, sticking to its stated intent of M&A being one of the key drivers of its future as a global generic and specialty company.